Ryan Toma

Ryan Toma

Auto-generated profile, based on publicly available information

Ryan Toma

Viome Research Institute, Viome Life Sciences, Inc., Seattle, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2021 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
GBGuru Banavar
Guru Banavar
OOOyetunji Ogundijo
Oyetunji Ogundijo
RTRyan Toma
Ryan Toma
SRSathyapriya Rajagopal
Sathyapriya Rajagopal
YLYen Kai Lim
Yen Kai Lim
Chamindie K. PunyadeeraChamindie K. Punyadeera
Chamindie K. Punyadeera
Despite advances in cancer treatment, the 5-year mortality rate for oral cancers (OC) is 40%, mainly due to the lack of early diagnostics. To advance early diagnostics for high-risk and average-risk populations, we developed and evaluated machine-learning (ML) classifiers using metatranscriptomic data from saliva samples (n = 433) collected from oral premalignant disorders (OPMD), OC patients (n = 71) and normal controls (n = 171). Our diagnostic classifiers yielded a receiver operating characteristics (ROC) area under the curve (AUC) up to 0.9, sensitivity up to 83% (92.3% for stage 1 cancer) and specificity up to 97.9%. Our metatranscriptomic signature incorporates both taxonomic and functional microbiome features, and reveals a number of taxa and functional pathways associated with OC. We demonstrate the potential clinical utility of an AI/ML model for diagnosing OC early, opening a new era of non-invasive diagnostics, enabling early intervention and improved patient outcomes.

1 October 2019 in International Journal of Genomics
Verified
Journal Article
Open access
PDF file
AHAndrew Hatch
Andrew Hatch
JHJames Horne
James Horne
RTRyan Toma
Ryan Toma
BTBrittany L. Twibell
Brittany L. Twibell
KSKalie M. Somerville
Kalie M. Somerville
MVMomchilo Vuyisich
Momchilo Vuyisich
A functional readout of the gut microbiome is necessary to enable precise control of the gut microbiome’s functions, which support human health and prevent or minimize a wide range of chronic diseases. Stool metatranscriptomic analysis offers a comprehensive functional view of the gut microbiome, but despite its usefulness, it has rarely been used in clinical studies due to its complexity, cost, and bioinformatic challenges. This method has also received criticism due to potential intrasample variability, rapid changes, and RNA degradation. Here, we describe a robust and automated stool metatranscriptomic method, called Viomega, which was specifically developed for population-scale studies. Viomega includes sample collection, ambient temperature sample preservation, total RNA extraction, physical removal of ribosomal RNAs (rRNAs), preparation of directional Illumina libraries, Illumina sequencing, taxonomic classification based on a database of >110,000 microbial genomes, and quantitative microbial gene expression analysis using a database of ~100 million microbial genes. We applied this method to 10,000 human stool samples and performed several small-scale studies to demonstrate sample stability and consistency. In summary, Viomega is an inexpensive, high-throughput, automated, and accurate sample-to-result stool metatranscriptomic technology platform for large-scale studies and a wide range of applications.

10 August 2020 in BioTechniques
Verified
Journal Article
Open access
RTRyan Toma
Ryan Toma
NDNathan Duval
Nathan Duval
BPBenjamin Pelle
Benjamin Pelle
MPMatthew M Parks
Matthew M Parks
VGVishakh Gopu
Vishakh Gopu
MVMomchilo Vuyisich
Momchilo Vuyisich
To prevent and treat chronic diseases, including cancer, a global application of systems biology is needed. We report here a whole blood transcriptome test that needs only 50 μl of capillary (finge... METHOD SUMMARY This report describes an important improvement to whole blood transcriptome analysis. While current methods are complicated and expensive, the method reported here includes at-home s...

9 January 2023 in BioTechniques
Verified
Journal Article
Open access
RTRyan Toma
Ryan Toma
YCYing Cai
Ying Cai
OOOyetunji Ogundijo
Oyetunji Ogundijo
LHLan Hu
Lan Hu
SGStephanie Gline
Stephanie Gline
MVMomchilo Vuyisich
Momchilo Vuyisich
The authors report here the development of a high-throughput, automated, inexpensive and clinically validated saliva metatranscriptome test that requires less than 100 μl of saliva. RNA is preserve... Method summary This paper introduces a novel method for the preservation and metatranscriptomic analysis of low volumes of saliva. The method involves mixing saliva with a preservative at the time ...

18 September 2025 in ACR Open Rheumatology
Verified
Journal Article
Open access
SESharon Erdrich
Sharon Erdrich
Ingrid C. GelissenIngrid C. Gelissen
Ingrid C. Gelissen
RTRyan Toma
Ryan Toma
MVMomchilo Vuyisich
Momchilo Vuyisich
Joanna E HarnettJoanna E Harnett
Joanna E Harnett
Objective: To describe the composition of the gut microbiota of women living with fibromyalgia, compared with controls, and examine the relationship between fecal microbiota and clinical features of fibromyalgia.Methods: New Zealand women meeting American College of Rheumatology fibromyalgia criteria and age‐matched controls provided fecal samples and completed validated surveys assessing pain, disorders of gut–brain interaction (DGBI), headaches, sleep quality, oral health, cognition, anxiety, depression, diet, and quality of life. Metatranscriptomic analysis identified phyla, genera, and species in fecal samples. Correlation coefficients were calculated for each α‐diversity metric against clinical variables. Welch's t‐test or Wilcoxon rank test was applied for binary clinical variables. Generalized linear models analyzed associations in the fibromyalgia group, adjusting for age, body mass index, and diet. Data processing and analysis used R version 4.2.1, with the Benjamini–Hochberg formula controlling for false discovery rate at ≤0.10 to minimize type 1 error risk.Results: No statistically significant differences were seen in the microbial expression in fecal samples of women with fibromyalgia (n = 104) compared with controls (n = 52). Significant associations among three species from the Bacteroidetes phylum and cognitive impairment were observed. Fusobacteriota was significantly associated with Rome IV(B) DGBI, specifically epigastric pain syndrome. A strong association was observed between oral microbiota in feces and upper gastrointestinal DGBI, indicating both negative and positive correlations in this population.Conclusion: No overall differences in fecal microbial expression were found in women with fibromyalgia. However, Bacteroidetes and Fusobacteriota phyla were significantly associated with cognitive impairment and epigastric pain syndrome, respectively. image

1 June 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
RTRyan Toma
Ryan Toma
NDNathan Duval
Nathan Duval
NSNan Shen
Nan Shen
PTPedro J. Torres
Pedro J. Torres
FCFrancine R. Camacho
Francine R. Camacho
MVMomchilo Vuyisich
Momchilo Vuyisich
Infectious diseases are common but are not easily or readily diagnosed with current methodologies. This problem is further exacerbated by the constant presence of mutated, emerging, and novel pathogens. One of the most common sites of infection by many pathogens is the human throat. However, there is no universal diagnostic test that can distinguish these pathogens. Metatranscriptomic (MT) analysis of the throat represents an important and novel development in infectious disease detection and characterization, because it is able to identify all pathogens using a fully unbiased approach. To test the utility of an MT approach to pathogen detection, throat samples were collected from participants before, during, and after an acute sickness. Clear sickness-associated shifts in pathogenic microorganisms were detected in the patients. Important insights into microbial functions and antimicrobial resistance genes were obtained. MT analysis of the throat represents an effective method for the unbiased identification and characterization of pathogens. Because MT data include all microorganisms in the sample, this approach should not only allow the identification of pathogens, but provide an understanding of the effects of the resident throat microbiome in the context of human health and disease.